6533b828fe1ef96bd12884d7
RESEARCH PRODUCT
Identifying Biomarkers for Biological Age: Geroscience and the ICFSR Task Force
Roger A. FieldingNathan K. LebrasseurLuigi FerrucciR. De CaboLeocadio Rodríguez-mañasBruno VellasJose Viñasubject
0301 basic medicineGerontologyAgingmedia_common.quotation_subjecthallmarks of agingTranslational researchfrailty03 medical and health sciencesSpecial Article030502 gerontologymedicineAnimalsHumansEpigeneticsFunction (engineering)Pandemicsresiliencemedia_commonGeroscienceSARS-CoV-2business.industryTask forceCOVID-19General Medicinemedicine.diseaseOmics030104 developmental biologyProteostasistranslational researchSarcopenia0305 other medical sciencebusinessBiomarkersdescription
The International Conference on Frailty and Sarcopenia Research Task Force met in March 2020, in the shadow of the COVID-19 pandemic, to discuss strategies for advancing the interdisciplinary field of geroscience. Geroscience explores biological mechanisms of aging as targets for intervention that may delay the physiological consequences of aging, maintain function, and prevent frailty and disability. Priorities for clinical practice and research include identifying and validating a range of biomarkers of the hallmarks of aging. Potential biomarkers discussed included markers of mitochondrial dysfunction, proteostasis, stem cell dysfunction, nutrient sensing, genomic instability, telomere dysfunction, cellular senescence, and epigenetic changes. The FRAILOMICS initiative is exploring many of these through various omics studies. Translating this knowledge into new therapies is being addressed by the U.S. National Institute on Aging Translational Gerontology Branch. Research gaps identified by the Task Force include the need for improved cellular and animal models as well as more reliable and sensitive measures.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2021-06-09 | The Journal of Frailty & Aging |